Bunkerhill AVC vs QIR Suite
AI Verdict
Choose Bunkerhill AVC if…
Choose Bunkerhill AVC if your institution seeks to leverage existing chest CTs for opportunistic, automated detection and quantification of aortic valve calcification and other cardiac calcifications, seamlessly integrating these insights into your EHR workflows. This tool is ideal for enhancing early detection and clinical reasoning across a broad patient population through its generative AI platform.
View Bunkerhill AVC →Choose QIR Suite if…
Choose QIR Suite if your clinical practice requires in-depth, quantitative analysis of both MR and CT cardiovascular images for comprehensive diagnostic and prognostic evaluation. This software excels at providing detailed metrics, including blood flow, myocardial perfusion, and strain quantification, making it suitable for advanced cardiac imaging analysis on dedicated local hardware.
View QIR Suite →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Bunkerhill AVC | QIR Suite |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Unknown | Locally on dedicated hardware |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Bunkerhill AVCTool A emphasizes deep EHR integration, generative AI for clinical reasoning, and natural language processing through Carebricks Chat, suggesting a highly integrated and intuitive user experience within existing clinical workflows. Its 'no-code' platform allows clinicians to build and deploy AI agents, offering greater flexibility and ease of customization compared to Tool B's focus on optimized ergonomics for image analysis.
Clinical Value
QIR SuiteWhile both tools are FDA-cleared and offer significant clinical value, Tool B provides a broader and deeper quantitative analysis of MR and CT images for a wider range of cardiovascular conditions, including over 100 clinical parameters, blood flow, perfusion, and strain quantification. It also claims to be the 'world first solution to automatically evaluate a myocardial infarction'. Tool A focuses on opportunistic detection of specific calcifications and bone density, leveraging generative AI for broader clinical reasoning.
Pricing & Value
QIR SuiteBoth tools require contacting for pricing, but Tool B offers more transparency by explicitly stating two pricing models: a 'One-time license fee' and 'Subscription' options. This provides potential customers with clearer information on available acquisition models, offering greater flexibility and perceived value transparency compared to Tool A's generic 'contact for pricing'.
Enterprise Readiness
Bunkerhill AVCTool A explicitly states HIPAA compliance and BAA availability, along with deep integration capabilities with full EHRs and clinical archives within health systems. It is also deployed in major health systems like UTMB Health, Cleveland Clinic, and Mayo Clinic, demonstrating strong enterprise adoption and a robust security framework.
Innovation
Bunkerhill AVCTool A showcases higher innovation through its generative AI platform for clinical reasoning and action, customizable AI agents, and natural language processing for patient record interaction (Carebricks Chat). It has been recognized as one of 'Fast Company's Most Innovative Companies of 2026' and for 'Best in AI Implementation,' highlighting its cutting-edge approach beyond traditional image analysis.
Support & Docs
QIR SuiteWhile both companies provide contact information and general resources, Tool B explicitly mentions a 'CASIS Academy,' suggesting a more formalized and structured approach to user education and training. This indicates a dedicated effort to provide comprehensive support and documentation beyond basic contact and news updates.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Bunkerhill AVC | QIR Suite |
|---|---|---|
| Product Name | Bunkerhill AVC | QIR Suite |
| Company | BunkerHill Health | CASIS Cardiac Simulation & Imaging Software |
| Primary Description Focus | Generative AI platform for clinical reasoning and action, integrating with EHRs to automate workflows and improve patient outcomes. FDA-cleared algorithm (Bunkerhill AVC) aids in early detection and quantification of aortic valve calcification from chest CTs. | AI-based medical imaging analysis software for cardiovascular conditions, offering quantitative evaluation of MR and CT images to support diagnosis and prognosis. |
| Key Imaging Analysis Capabilities | Automated detection and quantification of aortic valve calcification (Bunkerhill AVC), coronary artery calcification (iCAC, Contrast CAC), mitral annular calcification (Bunkerhill MAC), opportunistic bone density assessment (Bunkerhill BMD). | AI-based analysis of MR and CT examinations, detection of heart regions and pathological areas, quantification of over 100 clinical parameters, automatic segmentation, blood flow/velocities quantification, pathological volumes detection and quantification, semi-quantification of myocardial perfusion, strain quantification. |
| Broader AI Capabilities | Generative AI for clinical reasoning and action, customizable AI agents for diverse workflows, natural language processing for patient record interaction (Carebricks Chat). | Not specified |
Videos
Demos, reviews, and walkthroughs featuring Bunkerhill AVC and QIR Suite.